Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07116486) titled 'Phase 1, Single-site, Single-arm, Clinical Imaging, and Blood-based Biomarker Trial Utilizing 18F-FSPG PET to Guide Therapy in Hepatocellular Carcinoma' on Aug. 7.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: M.D. Anderson Cancer Center
Condition:
Hepatocellular Carcinoma
Intervention:
Diagnostic Test: Radiopharmaceutical 18F-FSPG
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: December 31, 2025
Target Sample Size: 60
Countries of Recruitment:
Un...